Go to Content Go to Navigation Go to Navigation Go to Site Search Homepage

This year, as we marked the second anniversary of the U.S. Supreme Court's 2022 Dobbs decision that stripped away our federal constitutional right to abortion, we found ourselves amidst another high-stakes court season where reproductive freedom faced significant threats at the federal level. These ongoing legal battles have exacerbated barriers to essential reproductive health care, leaving many people grappling with increased uncertainty, fear, and confusion about how to get the care they need.

Mifepristone: The Fight Continues

The Supreme Court ruled that a group of anti-abortion physicians does not have standing to challenge the FDA’s actions related to the approval of mifepristone. Mifepristone will remain on the market and accessible in states where abortion is legal. However, this attack on medication abortion could continue, as the case will be sent back down to federal district court judge Matthew Kacsmaryk, who has already allowed the states of Kansas, Missouri, and Idaho to intervene in the case.

Mifepristone is safe, effective, and has been used by over five million people in the United States for abortion and miscarriage care since the FDA approved it more than 20 years ago. Lawmakers and judges are not more qualified than you and your health care provider to make your own personal health care decisions.

Our health centers continue to provide medication abortion and are expanding our medication abortion telehealth program to meet the needs of our patients. From April 1, 2023, to March 31, 2024, medication abortion accounted for 66% of all abortion care at PPSNE, further proving the need for medication abortion to be widely accessible so our patients can make the best decisions for their lives and futures.

EMTALA: Appeal Dismissed, We Remain Vigilant

For nearly six months, as a direct result of the U.S. Supreme Court’s actions, Idahoans were denied access to emergency abortion care. While access to emergency abortion care has been restored in Idaho for now, the court had the opportunity to make clear that the federal EMTALA law protects pregnant patients’ access to emergency abortion care in every state. Instead, the court has kicked the can down the road, leaving access to emergency care for pregnant people across the country under threat, further fueling the ongoing public health crisis sparked by the overturning of Roe v. Wade.

For nearly 40 years, EMTALA has guaranteed access to emergency medical treatment, including abortion. Post-Roe, over 20 states have severely restricted or banned abortion, creating conflicts with EMTALA and forcing providers to navigate complex legal scenarios during emergencies.

At Planned Parenthood of Southern New England, we remain resolute in our mission to provide compassionate care despite these attacks. Our unwavering commitment to our community's health and well-being means our doors remain open, offering comprehensive reproductive health care, including contraception, cancer screenings, STI testing, abortion care, and more. We never stop fighting for the respect and protection of your rights and personal health care decisions. Your support is crucial as we navigate these challenging times and advocate for a future where reproductive freedom is a reality for all.

 

Tags: Supreme Court, SCOTUS, MIFE

Explore more on

Español

This website uses cookies

Planned Parenthood cares about your data privacy. We and our third-party vendors use cookies and other tools to collect, store, monitor, and analyze information about your interaction with our site to improve performance, analyze your use of our sites and assist in our marketing efforts. You may opt out of the use of these cookies and other tools at any time by visiting Cookie Settings. By clicking “Allow All Cookies” you consent to our collection and use of such data, and our Terms of Use. For more information, see our Privacy Notice.

Cookie Settings

Planned Parenthood cares about your data privacy. We and our third-party vendors, use cookies, pixels, and other tracking technologies to collect, store, monitor, and process certain information about you when you access and use our services, read our emails, or otherwise engage with us. The information collected might relate to you, your preferences, or your device. We use that information to make the site work, analyze performance and traffic on our website, to provide a more personalized web experience, and assist in our marketing efforts. We also share information with our social media, advertising, and analytics partners. You can change your default settings according to your preference. You cannot opt-out of required cookies when utilizing our site; this includes necessary cookies that help our site to function (such as remembering your cookie preference settings). For more information, please see our Privacy Notice.

Marketing

On

We use online advertising to promote our mission and help constituents find our services. Marketing pixels help us measure the success of our campaigns.

Performance

On

We use qualitative data, including session replay, to learn about your user experience and improve our products and services.

Analytics

On

We use web analytics to help us understand user engagement with our website, trends, and overall reach of our products.